About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Philadelphia | 133 Studies

Clinical Trials EpilepsyPhiladelphia

Epilepsy Clinical Trials in Philadelphia

Find 133 clinical trials for epilepsy near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 133 trials

CompletedEfficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.To evaluate the efficacy and safety of diazepam in the management of refractory epilepsy in selected patients who require intermittent medical intervention for the control of…NCT00319501·Northport, Alabama and 85 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset SeizuresA study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset SeizuresNCT03116828·Mobile, Alabama and 54 others

TerminatedA Long-term Safety and Tolerability Study of USL261 in Patients With Seizure ClustersThe purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.NCT02161185·Tucson, Arizona and 15 others

CompletedRNS® System LTT StudyThe RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of…NCT00572195·Phoenix, Arizona and 32 others

CompletedTrial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset SeizuresThis open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset…NCT00530855·Alabaster, Alabama and 107 others

CompletedPhase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label ExtensionThe study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3…NCT01963208·Birmingham, Alabama and 70 others

CompletedStudy to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUThis study is designed to evaluate the efficacy, safety, and tolerability of USL261 compared with that of intranasal (IN) placebo for the treatment of intermittent bouts of…NCT01999777·Phoenix, Arizona and 50 others

CompletedThis Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam TreatmentThis trial, evaluating the long-term safety and tolerability of brivaracetam will provide subjects suffering from epilepsy, who may have benefited from brivaracetam as adjunctive…NCT00150800·Phoenix, Arizona and 99 others

CompletedAn Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeThis is an international, multicenter, open-label, long-term safety study of ZX008 in subjects with Dravet syndrome.NCT02823145·Phoenix, Arizona and 66 others

TerminatedAn Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.NCT04686786·Little Rock, Arkansas and 55 others

CompletedEslicarbazepine Acetate Monotherapy Long Term StudyThis is a long term, open-label, safety extension study in subjects with partial onset seizures.NCT00910247·Northport, Alabama and 121 others

CompletedPediatric Epilepsy StudyThis study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as add-on therapy in the treatment of partial seizures in pediatric patients 1 month to 3 years…NCT00050934·Birmingham, Alabama and 29 others

CompletedRegistry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.NCT03529045·Grand Junction, Colorado and 61 others

CompletedTopiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresThe purpose of this study is to evaluate the tolerability, safety and efficacy of topiramate in infants with refractory partial onset seizures (POS).NCT00113815·Birmingham, Alabama and 93 others

CompletedOpen-label Extension to Protocol 1042-0600To allow open-label extension to patients who have completed Protocol 1042-0600.NCT00512317·Birmingham, Alabama and 24 others

CompletedValidation Study of the Simplified Seizure Classification AlgorithmAn algorithm has been developed for simplified classification of epileptic seizures, in order to optimize choice of antiepileptic drugs.NCT03796520·Philadelphia, Pennsylvania and 4 others

CompletedA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe goal of this clinical trial is to learn if CVL-865, when taken regularly with other anti-seizure medicines, works to prevent seizures in adults with drug-resistant focal onset…NCT04244175·Little Rock, Arkansas and 75 others

CompletedRetigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in EpilepsyThis Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients…NCT00232596·Birmingham, Alabama and 53 others

CompletedA Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure EpisodeThe purpose of this study is to determine the pharmacokinetics of Diazepam Nasal Spray following a single dose in epileptic patients experiencing a seizure episode.NCT01417078·Phoenix, Arizona and 3 others

Enrolling by invitationAn Open-label Study of XEN1101 in EpilepsyThis study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FOS) or Primary Generalized…NCT05718817·Phoenix, Arizona and 151 others

PreviousPage 5 of 7Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia